Frequent copresence of methylated DNA and fragmented nucleosomal DNA in plasma of lymphoma patients

被引:37
作者
Deligezer, U
Yaman, F
Erten, N
Dalay, N [1 ]
机构
[1] Univ Istanbul, Dept Basic Oncol, Istanbul, Turkey
[2] Univ Istanbul, Dept Radiat Oncol, Istanbul, Turkey
[3] Univ Istanbul, Istanbul Fac Med, Dept Internal Med, Istanbul, Turkey
关键词
lymphoma; plasma DNA; fragmentation; p16; methylation;
D O I
10.1016/S0009-8981(03)00279-1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The circulating DNA in plasma/serum of cancer patients has been shown to reflect the characteristics of the tumor DNA including molecular changes, such as rnethylation, point mutations and microsatellite instability. Fragmented nucleosomal DNA in plasma resulting from apoptotic death of the tumor cells may also provide an indication for tumor DNA. In this study, we comparatively analysed plasma DNA methylation and presence of fragmented nucleosomal DNA in patients with lymphoproliferative diseases. Methods: Methylation in the first exon of the tumor supressor gene p16 was investigated by the methylation-sensitive restriction enzyme-related PCR. DNA fragmentation in plasma was analysed by gel electrophoresis. Results: p16 gene methylation was found to occur in 73% of patients but in none of the 20 healthy controls. Nucleosomal DNA fragmentation was detectable in 81% of patients. In 67% of patients, copresence of both parameters was observed. Presence of both parameters a frequent event and may be used as a marker for early diagnosis and during the follow-up of the disease. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 25 条
[1]  
An Q, 2002, CANCER LETT, V188, P109, DOI 10.1016/S0304-3835(02)00496-2
[2]  
Anker P, 2000, ANN NY ACAD SCI, V906, P5
[3]   Frequent methylation silencing of p15INK4b (MTS2) and p16INK4a (MTS1) in B-cell and T-cell lymphomas [J].
Baur, AS ;
Shaw, P ;
Burri, N ;
Delacrétaz, F ;
Bosman, FT ;
Chaubert, P .
BLOOD, 1999, 94 (05) :1773-1781
[4]   Apoptotic index as a prognostic factor in Hodgkin's disease [J].
Benharroch, D ;
Levy, A ;
Prinsloo, I ;
Ariad, S ;
Rabinovitch, D ;
Shendler, Y ;
Sacks, M ;
Gopas, J .
LEUKEMIA & LYMPHOMA, 1999, 33 (3-4) :351-359
[5]   Inactivation of tumor suppressor genes p15INK4b and p16INK4a in primary cutaneous b cell lymphoma [J].
Child, FJ ;
Scarisbrick, JJ ;
Calonje, E ;
Orchard, G ;
Russell-Jones, R ;
Whittaker, SJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (06) :941-948
[6]  
Esteller M, 1999, CANCER RES, V59, P67
[7]  
Esteller M, 2001, CANCER RES, V61, P3225
[8]  
García JF, 1999, LAB INVEST, V79, P1453
[9]   Different incidence and pattern of p151NK4b and p161NK4a promoter region hypermethylation in Hodgkin's and CD30-Positive non-Hodgkin's lymphomas [J].
García, MJ ;
Martínez-Delgado, BM ;
Cebrian, A ;
Martínez, A ;
Benítez, J ;
Rivas, C .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (03) :1007-1013
[10]  
HERMAN JG, 1995, CANCER RES, V55, P4525